CHYPHNX
Architecture, research and IP-governance layer across the technology portfolio. Public presentation does not imply that every program is a separate legal entity.
Federated portfolio architecture
SEPARATE
BY DESIGN.
Shared governance does not require a single monolithic brand. Products can begin under CPX, earn independent domains and operating lanes, and remain connected to the wider portfolio without duplicating the same public identity.
One enduring corporate standard
THE CHYPHNX VERDICT.
EVERY PRODUCT ANSWERS.
CPX/CHYPHNX operates with one evidence-led ethics standard across security, mission systems, human systems, quantitative research and independently branded consumer products. Truth, dignity, lawful pay, authorized practice, accountability and stewardship apply at every level. Each product retains its own data, security and legal boundaries.
THE RESULT IS WHAT YOU BUY. THE PROOF IS WHAT WE OWE. The 357 Doctrine demands consequence, proof and legacy; truth, authority, contribution, distinction and endurance; and seven verdict gates before a claim is accepted. Read the complete CHYPHNX Verdict.
NO TITLE ABOVE ACCOUNTABILITY. INCLUDING OWNERSHIP. The person preventing failure matters as much as the person presenting success. Participation and ownership opportunities require actual legal and funded plans; this is not an equity offer or job advertisement. Explore our people and 357 culture.
Portfolio layers
ONE FAMILY.
INDEPENDENT ASSETS.
Domains, brands and product surfaces are separated when separation improves trust, focus, ownership clarity or future optionality.
CPX AGENCY
The commercial and governance interface: define the customer problem, assemble legitimate expertise, cost the engagement, verify delivery and protect every contributor. Outcome first, technology second.
GHOSTsuite
SECURE: develop defensible identity, policy, protection and resilience capabilities. Every security claim must have authorized tests and a stated deployment maturity; no certification or unapproved federal-data readiness is implied.
Open GHOSTsuiteMissionGrid
DECIDE: develop mission modeling, orbital and space systems and evidence-led decision support. Provenance and uncertainty matter; simulation or research must not be sold as verified field performance.
Theron / DRYAD / Apollo Helix
ADVANCE: research technology that makes complex health and human workflows more understandable and useful. THERON is the health systems flagship; clinical effectiveness, licensed practice and patient-data rights require separate proof and authority.
FINCH
ADVANCE: an independent AI companion concept focused on trusted, understandable assistance and user control. It is not a GHOST governance service; safety, privacy and working capability must be validated separately.
Omega
BUILD: bounded quantitative and cross-asset market research with documented hypotheses, downside and uncertainty. Research does not establish trading authorization, investor returns or a regulated financial service.
CLICO
BUILD: an independent luxury and consumer identity where actual materials, design, provenance and workmanship must support every claim. Its primary brand domain is clico.global; separate consumer IP and economics remain intact.
INCUBATE → GRADUATE
A product may begin as a CPX route, move to its own domain when commercially ready, and retain a portfolio page on CPX for provenance, discovery and institutional context.
This page describes public portfolio architecture and brand/domain strategy. Legal entity ownership, licensing and IP assignments are governed separately and should not be inferred from website navigation alone.